Effect of cardiac resynchronization therapy on cardiac sympathetic nervous dysfunction and serum C-reactive protein level

PACE - Pacing and Clinical Electrophysiology

Volumn 34, Issue 10, 2011, Pages 1225-1230

  Shinohara, Tetsuji ^a   Takahashi, Naohiko ^a   Saito, Syotaro ^a   Okada, Norihiro ^a   Wakisaka, Osamu ^a   Yufu, Kunio ^a   Hara, Masahide ^a   Nakagawa, Mikiko ^a   Saikawa, Tetsunori ^a   Yoshimatsu, Hironobu ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

C reactive protein; cardiac MIBG scintigraphy; cardiac resynchronization therapy; cardiac sympathetic nervous dysfunction; heart failure

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC SYMPATHETIC NERVOUS DYSFUNCTION; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART SCINTISCANNING; HUMAN; MALE; NONISCHEMIC CARDIOMYOPATHY; SYMPATHETIC NERVE;

AGED; C-REACTIVE PROTEIN; CARDIAC RESYNCHRONIZATION THERAPY; CHRONIC DISEASE; FEMALE; HEART; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; STROKE VOLUME; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 80054726044     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2011.03156.x     Document Type: Article

References (26)

1. Leimbach WN, Jr,., Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL,. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986; 73: 913-919. (Pubitemid 16102181)
2. Ferguson DW, Berg WJ, Sanders JS,. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: Evidence from direct microneurographic recordings. J Am Coll Cardiol 1990; 16: 1125-1134. (Pubitemid 20378462)
3. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, et al,. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-823. (Pubitemid 14035089)
4. Ogita H, Shimonagata T, Fukunami M, Kumagai K, Yamada T, Asano Y, Hirata A, et al,. Prognostic significance of cardiac (123)i metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: A prospective study. Heart 2001; 86: 656-660. (Pubitemid 33086883)
5. Anastasiou-Nana MI, Terrovitis JV, Athanasoulis T, Karaloizos L, Geramoutsos A, Pappa L, Tsagalou EP, et al,. Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2005; 96: 427-431. (Pubitemid 41058876)
6. Kaneko K, Kanda T, Yamauchi Y, Hasegawa A, Iwasaki T, Arai M, Suzuki T, et al,. C-reactive protein in dilated cardiomyopathy. Cardiology 1999; 91: 215-219. (Pubitemid 29502082)
7. Yin WH, Chen JW, Jen HL, Chiang MC, Huang WP, Feng AN, Young MS, et al,. Independent prognostic value of elevated high-sensitivity c-reactive protein in chronic heart failure. Am Heart J 2004; 147: 931-938. (Pubitemid 38881011)
8. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L,. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549. (Pubitemid 40517094)
9. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, et al,. Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The task force for the diagnosis and treatment of chronic heart failure of the European society of cardiology. Eur Heart J 2005; 26: 1115-1140.
10. Bonow RO, Bennett S, Casey DE, Jr,., Ganiats TG, Hlatky MA, Konstam MA, Lambrew CT, et al,. ACC/AHA clinical performance measures for adults with chronic heart failure: A report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol 2005; 46: 1144-1178. (Pubitemid 41316528)
11. Gademan MG, van Bommel RJ, Borleffs CJ, Man S, Haest JC, Schalij MJ, van der Wall EE, et al,. Biventricular pacing-induced acute response in baroreflex sensitivity has predictive value for midterm response to cardiac resynchronization therapy. Am J Physiol Heart Circ Physiol 2009; 297: H233-H237.
12. Ritter P, Padeletti L, Gillio-Meina L, Gaggini G,. Determination of the optimal atrioventricular delay in DDD pacing. Comparison between echo and peak endocardial acceleration measurements. Europace 1999; 1: 126-130.
13. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, et al,. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
14. La Rovere MT, Bigger JT, Jr,., Marcus FI, Mortara A, Schwartz PJ,. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Atrami (autonomic tone and reflexes after myocardial infarction) investigators. Lancet 1998; 351: 478-484. (Pubitemid 28070094)
15. Schofer J, Spielmann R, Schuchert A, Weber K, Schluter M,. Iodine-123 meta-iodobenzylguanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988; 12: 1252-1258.
16. Imamura Y, Ando H, Mitsuoka W, Egashira S, Masaki H, Ashihara T, Fukuyama T,. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol 1995; 26: 1594-1599.
17. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, Agostini D, et al,. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (ADreview Myocardial Imaging for Risk Evaluation in Heart Failure) Study. J Am Coll Cardiol 2010; 55: 2212-2221.
18. Seta Y, Shan K, Bozkurt B, Oral H, Mann DL,. Basic mechanisms in heart failure: The cytokine hypothesis. J Card Fail 1996; 2: 243-249.
19. Mann DL,. Mechanisms and models in heart failure: A combinatorial approach. Circulation 1999; 100: 999-1008. (Pubitemid 29407182)
20. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, Gardin JM, et al,. Predictors of congestive heart failure in the elderly: The cardiovascular health study. J Am Coll Cardiol 2000; 35: 1628-1637. (Pubitemid 30307510)
21. Adamson PB, Kleckner KJ, VanHout WL, Srinivasan S, Abraham WT,. Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 2003; 108: 266-269. (Pubitemid 36899014)
22. Fantoni C, Raffa S, Regoli F, Giraldi F, La Rovere MT, Prentice J, Pastori F, et al,. Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. J Am Coll Cardiol 2005; 46: 1875-1882. (Pubitemid 41579811)
23. Erol-Yilmaz A, Verberne HJ, Schrama TA, Hrudova J, De Winter RJ, Van Eck-Smit BL, De Bruin R, et al,. Cardiac resynchronization induces favorable neurohumoral changes. Pacing Clin Electrophysiol 2005; 28: 304-310. (Pubitemid 40613059)
24. Burri H, Sunthorn H, Somsen A, Fleury E, Stettler C, Shah D, Righetti A,. Improvement in cardiac sympathetic nerve activity in responders to resynchronization therapy. Europace 2008; 10: 374-378. (Pubitemid 351773736)
25. Yu CM, Fung WH, Lin H, Zhang Q, Sanderson JE, Lau CP,. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 2003; 91: 684-688. (Pubitemid 36287458)
26. Cha YM, Oh J, Miyazaki C, Hayes DL, Rea RF, Shen WK, Asirvatham SJ, et al,. Cardiac resynchronization therapy upregulates cardiac autonomic control. J Cardiovasc Electrophysiol 2008; 19: 1045-1052.